CLOVER CORPORATION LIMITED (CLV)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

CLV - CLOVER CORPORATION LIMITED
FNArena Sector : Health & Nutrition
Year End: July
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 1.02
Index: ALL-ORDS
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.10
21 Sep |
0.000 OPEN $1.10 |
0.000 HIGH $1.10 |
15,160 LOW $1.07 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 0% |
OTHER COMPANIES IN THE SAME SECTOR | |||
EBO . EXL . MCP . SIG . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY21 Actual |
FY22 Actual |
FY23 Forecast |
FY24 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 4.3 | 4.0 | xxx |
DPS (cps) | xxx | 1.5 | 1.0 | xxx |
EPS Growth | xxx | 18.8% | - 6.8% | xxx |
DPS Growth | xxx | 50.0% | - 33.3% | xxx |
PE Ratio | xxx | N/A | 27.5 | xxx |
Dividend Yield | xxx | N/A | 0.9% | xxx |
Div Pay Ratio(%) | xxx | 35.0% | 25.0% | xxx |
Last ex-div: 05/04 - ex-div 0.75c (franking 0%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 4.3 |
DPS All | xxx | xxx | xxx | xxx | xxx | 1.5 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 70.7 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 37.9 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 6.6 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 10.09 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 11.75 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 9.89 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 8.42 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 11.75 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 15.05 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 3.3 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 2 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 10 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 12 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 2 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 10 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 2.84 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 1.6 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 2.26 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 49 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 10 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | 2 M |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 12 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
CLV STOCK CHART

FNArena News on CLV
1 |
Weekly Ratings, Targets, Forecast Changes – 17-03-23Mar 20 2023 - Weekly Reports |
2 |
FNArena Corporate Results Monitor – 17-03-2023Mar 17 2023 - Australia |
3 |
FNArena Corporate Results Monitor – 26-09-2022Sep 26 2022 - Australia |
4 |
Weekly Ratings, Targets, Forecast Changes – 16-09-22Sep 19 2022 - Weekly Reports |
5 |
Weekly Ratings, Targets, Forecast Changes – 18-03-22Mar 21 2022 - Weekly Reports |
Latest Health & Nutrition News
1 |
Sigma’s Win Not Neccessarily Ebos’ LossJun 14 2023 - Small Caps |
2 |
Sigma Healthcare: Brokers WaryMar 31 2022 - Australia |
3 |
Health & Wellness Boom On The ASXApr 29 2021 - Weekly Reports |
4 |
M&A Now On Sigma Healthcare’s AgendaMar 24 2021 - Australia |
5 |
McPherson’s Expands Into Herbal HealthNov 04 2020 - Small Caps |
6 |
Nine Ignored Companies Now Worth A LookSep 23 2020 - FYI |
7 |
Next Week At A Glance – 14-18 Sep 2020Sep 11 2020 - Weekly Reports |
8 |
Sigma Farewells API, Heralds New ContractDec 17 2019 - Australia |
9 |
Blackmores: Hopes Pinned On RestructuringNov 01 2019 - Australia |
10 |
Blackmores Peps Up Its Strategy For ChinaApr 17 2019 - Australia |